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Abstract
The ruthenium(Ill) complex Hind trans-[RuCl,(ind)2], with two trans-standing indazole (ind)
ligands bound to ruthenium via nitrogen, shows remarkable activity in different tumor models
in vitro and in vivo. The solvolysis of the complex trans-[RuCl,(ind)2] has been investigated by
means of spectroscopic techniques (UV/vis, NMR)in different solvents. We investigated the
indazolium as well as the sodium salt, the latter showing improved solubility in water. In
aqueous acetonitrile and ethanol the solvolysis results in one main solvento complex. The
hydrolysis of the complex is more complicated and depends on the pH of the solution as well
as on the buffer system.
1. Introduction
Today, cisplatin is a well established chemotherapeutic drug, especially against testicular
carcinomas, but expansion to a different or broader antitumor spectrum has not been
obtained with cisplatin or direct analogues, like carboplatin. Some new developments like
orally administrable platinum complexes or combination therapy are promising, but attention
is more and more directed to non-platinum antitumor metal compounds. Among others,
ruthenium complexes of the oxidation state +11 and +111 are under current investigation as
alternative drugs to platinum-based tumor inhibitors [1,2,3,4]. Because of their different
chemical characteristics and kinetics, the mode of action and spectrum of activity of these
ruthenium compounds should differ significantly from the known platinum complexes. They
possess a different redox behavior and undergo different hydrolysis reactions. As a result, a
different interaction with biological targets can be expected and detected.
Especially ruthenium(Ill) complexes of the general formula HL[RuCI4L2], with two trans-
standing heterocyclic ligands L bound to ruthenium via nitrogen, show remarkable activity in
different tumor models in vitro and in vivo. They exhibit excellent activity in an
autochthonous colorectal tumor model, which is comparable to human colon tumors in its
histological appearance and behavior against chemotherapeutics, with a tumor reduction of
about 70% to 90% [5,6]. Cisplatin is completely inactive in this model. Furthermore, these
Ru(lll)-complexes show antiproliferative activity in two human colon cancer cell lines
(SW707 and SW948) [7]. The most promising complex contains two trans-standing indazole
(L = ind) ligands. It exhibits antineoplastic effects on proliferation of clonogenic cells from
freshly explanted human tumors in a capillary soft agar cloning system [8]. Compared to the
also very active imidazole (L = im) complex it is less toxic. The slightly different activity and
significantly different toxicological profile of the imidazole and indazole complexes might
be due to their different hydrolysis reactions and kinetics and binding preferences for
biological targets. Aquation is an important step in the activation of cisplatin [9] and aqua
complexes, in general, are orders of magnitude more labile than the corresponding chloro
complexes [10,11,12]. It is also known that only aged aqueous solutions of Him trans-
[RuCl,(im)2] react with DNA [13]. Therefore, the knowledge of hydrolysis or, in general,
solvolysis products is of great importance for a deeper understanding of the mode of action of
the ruthenium complexes.
The hydrolysis reactions of the imidazole complex Him trans-[RuCI,im2] have already been
investigated by means of 1H-NMR, EPR or UV/vis spectroscopy [14,15,16]. In each case
hydrolysis to a monoaqua complex has been proposed in unbuffered aqueous solution,
followed by the formation of both of the possible diaqua complex isomers with trans-standing
imidazoles. The situation in phosphate-buffered solution was found to be more complicated.
Here we report on the solvolysis in ethanol, acetonitrile and dimethylsulfoxide and the
hydrolysis of the indazole complex trans-[RuCI4(ind)2] (see figure a). We investigated the
indazolium as well as the sodium salt, the latter showing improved solubility in water.
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2. Materials and Methods
Solvents used were of analytical grade and dried with standard methods.
Elemental analysis C,H,N analysis were carried out on a Perkin Elmer 2400 CHN Elemental
Analyzer. CI was analyzed by argentometry.
Spectrophotometric experiments were performed in a thermostated cell compartment in a
Perkin Elmer Lambda 20 UV/vis spectrometer. H NMR experiments were performed at 400.13 MHz (H) on a Bruker DPX 400 spectrometer.
Hind trans-[RuCl,(ind)] [17] and Na trans-[RuCl,(ind)].3HO [18] were prepared as described
elsewhere. To obtain "water-free" Na trans-[RuCl,(ind)] for reactions in absolute solvents, the
trihydrate is dissolved in acetonitrile and the complex salt precipitated by addition of
diethylether and dried under vacuum. C,HCI,N,NaRu (502.15): calcd. C 33.49, H 2.41, N
11.16; found: C 33.33, H 2.66, N 11.05. H-NMR (400 MHz,.JD] acetonitrile): 5 4.31 (2 H),
3.18 (2 H), 2.63 (2 H), 2.44 (2 H),-7.1 (2 H),-12.9 (2 H) ppm. ’C-NMR (100 MHz, acetonitrile-
d3): 5 118.05, 114.71, 98.27, 97.75 ppm.
Precipitate obtained from a solution of Na trans-[RuCl,(ind)].3HO in water: The dark solid
that precipitated in a nearly saturated solution of Na trans-[RuCl,(ind)].3HO in water at room
temperature was filtered after one week. Elemental analysis, found: C 36.47, H 2.96, N 11.85,
CI 21.95, calculated for [RuCl(HO)(ind)], C,H,CINORu (461.72): C: 36.42, H 3.06, N
12.13, CI 23.04. H-NMR (400 MHz, dmso-d6): 5 4.49, 4.19, 3.71, 3.64, -4, -10 ppm and, with
2% relative peak area, 7.17, 7.40, 7.80, 8.75 ppm.
Precipitate obtained from a solution of Na trans-[RuCl,(ind)].3HO in acetonitrile water: The
dark solid that precipitated in a nearly saturated solution of Na trans-[RuCl,(ind)].3HO in
acetonitrile water (70/30) at room temperature was filtered after one week. Elemental
analysis, found: C: 39.71, H 2.95, N 14.37, CI 21.86, calculated for [RuCI(CHCN)(ind)],
CHCINRu (484.76): C 39.64, H 3.12, N 14.45, CI 21.94. H-NMR (400 MHz, CDCI): 5 9.09,
5.59, 5.10, 4.40,. 4.04, 2.89, 1.09,-2.22,-12 and-17 ppm.
3. Results and Discussion
3.1. Solvolysis of Na trans-[RuCl(ind)]
Na trans-[RuCl(ind)] does not react in acetonitrile within two days. No changes in H NMR-
and UV/vis-spectra can be seen. In the H NMR spectrum of Na trans-[RuCl,(ind)] the typical
line broadening and chemical shifts due to the paramagnetic Ru(lll)-center can be observed
[19,20]. The most upfield shifted signal at a chemical shift of-13.0 ppm represents the two
protons at position 3 of the two equivalent indazole ligands. The signal at -7.1 ppm can be
assigned to each proton at N-2 because it disappears, due to rapid exchange, on addition of
DO. The less broad and upfield shifted peaks at 2.45 (2 h at C-4 or C-7), 2.63 (2 H at C-7 or C-
4), 3.18 (2 H at C-5 or C-6) and 4.32 ppm (2 H at C-6 or C-5), that can be assigned in pairs
because of corresponding cross-peaks in the H,H-COSY experiment, represent the protons of
the indazole ligands with a greater distance to the paramagnetic Ru(lll)-center [18].
The possibility that the spectra in a fresh solution of Na trans-[RuCl,(ind)] do not represent the
structure determined for the solid complex salt [18], could be ruled out by evaporating the
solvent or precipitating the complex salt with diethylether and characterizing the obtained
product again. No changes in the IR- or H NMR-spectra could be observed.
If a mixture of acetonitrile water is used instead of pure acetonitrile, a transformation can be
seen in H NMR- and UV/vis-spectra. Na trans-[RuCl,ind] reacts in acetonitrile water (70/30),
the eluent mixture that is used as solvent in HPLC experiments of the compound, to a main
solvolysis product. Figure b shows the changes in H NMR-spectra taken during 72 hours at
room temperature. Four new peaks at a chemical shift of 3.77, 3.56, 0.44 and 0.11 ppm show
up while the intensity of the peaks representing the ,,original" complex trans-[RuCl,(ind)] at
3.65 (overlapping the new peak at 3.77), 3.10, 2.34 and 2.18 ppm decreases. The upfield
shifted peak at-14.9 disappears. No other signal could be observed. Precipitation occurs after
one week at room temperature. This precipitation was only observed at the concentrations
used in the NMR experiments. The precipitate is soluble in less polar solvents like chloroform.
Although the elemental analysis of the precipitate fits the calculated values for the neutral
monosolvento complex [RuCI(CHCN)(ind)], the H NMR data are not consistent with this
proposal. At least eight signals of nearly equal intensity between 9 and -2 ppm and two broad
signals at-12 and -17 ppm could be detected. Information from COSY spectra are limited
due to the paramagnetic Ru(lll) center but coupling between four of the ten signals could be
found.










Figure 1. a)Tumor-inhibiting Ru(lll) complex trans-[RuCl4ind2], b) 1H NMR-spectra of Na trans-
[RuCl,(ind)2] in CD3CN D20 (70/30) during 3 days at room temperature between a chemical shift of 0 to
3.8 ppm.
The changes observed in the UV/vis-spectra also confirm the formation of one main solvolysis
product of Na trans-[RuCI4ind2] in acetonitrile water mixtures. The original spectrum with
maxima at 239, 292 and 373 nm changes to give a spectrum with maxima at 279, 379, 398,
536 and 635 nm after 24 hours at 37C, as can be seen in figure 2a. Isosbestic points at 217,
282 and 314 nm indicate a definite transformation into one main solvolysis product. The
changes in the UV/vis-spectra are significantly different from those in pure water (see below).
Thus, solvolysis of Na trans-[RuCl4(ind)2] does not occur in absolute acetonitrile solution
within days, whereas it takes place in acetonitrile water mixtures. One explanation for these
findings could be an initial, rate-determining reaction of trans-[RuCl,(ind)ff with water,
presumably leading to the monoaquacomplex [RuCI3(HO)(ind)]. The monoaquacomplex
could then react with acetonitrile, forming an acetonitrile complex [RuCI3(CHzCN)(ind)], as
could be demonstrated in similar cases [21].
Figure 2. a) UV/vis-spectra (215-800 nm) of Na trans-[RuCl(ind)2] in acetonitrile water (70/30) during 48
hours at room temperature; b) UV/vis-spectra (250-750 nm) of Na trans-[RuCl,(ind)2] in dmso water (1/1)
during 12 hours at 37C.
As in the case of acetonitrile, no change in the 1H NMR of Na trans-[RuCl,(ind)2] can be
observed in absolute dmso-d6 solution within a week. The signals at-11.0 (2 H at C-3),-6.1 (2
H at N-2), 2.49 (2 H at C-4 or C-7), 3.22 (4 H at C-7 or C-4 and C-5 or C-6) and 4.40 ppm 2 H
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at C-6 or C-5) remain unchanged in intensity and chemical shift. The UV/vis-spectra in
absolute dmso don’t give any evidence for a transformation of the ruthenium complex either.
In contrast, the spectra of Na trans-[RuCI4(ind)2] change significantly in dmso water mixtures.
The UV/vis spectrum after 12 hours at 37C is totally different from the spectrum in
acetonitrile water and also different from the spectrum in water (see below). After one hour a
band occurs at 610 nm (in water at 580 nm), whereas the band at 377 nm disappears, as can
be seen in figure 2b. Isosbestic points can be found at 261, 283, 312 and 354 nm. No
prec!pitation occurs.
The ’H NMR experiment in dmso-d6 D20 does not lead to further information. No changes in
chemical shifts, only a decrease in intensity of the signals due to precipitation of a dark solid
can be observed.
The reaction of Na trans-[RuCl4(ind)2] in ethanol can be monitored by UV/vis- and NMR-
spectroscopy. Figure 3a shows the changes in the 1H NMR spectra of a solution of Na trans-
[RuCl,(ind)2] in ethanol-d4 in the chemical shift region of 2.0 to 4.2 ppm. The spectrum at the
bottom represents the 1H NMR of Na trans-[RuCl,(ind)2] just after dissolving in deuterated
ethanol. The peaks of the original complex anion appear at a chemical shift of 2.24, 2.49,
3.19 and 3.54 ppm. After two hours at 37C a peak at 3.13 ppm and two signals at 3.88 and
3.98 ppm arise (they can already be seen in the first spectrum), whereas the intensity of the
original peaks decreases. The increase in intensity of the new downfield-shifted signals
reaches a plateau after about 12 hours. The signal intensity ratio, original complex
solvolysis product, stays at about 1/3 even after one week. The signal pattern can be
attributed to one solvolysis product, as the increase in intensity is simultaneous and coupling
of the protons of this solvolysis product can be determined with a H,H-COSY experiment (data
not shown). The peaks at 3.13 and 3.98 ppm represent one proton each, the peak at 3.88
ppm represents two protons of each indazole ligand. Changes in 1H NMR spectra also occur
simultaneously in the down field region. The broad signal of the proton at position 3 of the
indazole ligand of the original complex anion trans-[RuCl,(ind)2] at-14.3 ppm disappears,
whereas a new signal rises at -11.3 ppm (see figure 3b). In the aromatic region multiplets at
7.26, 7.51, 7.74, 7.84 ppm and a singlet at 8.86 can be detected after six hours (data not
shown), showing the typical signal pattern for indazole. The signals are of very low intensity
(only about 2% of the main solvolysis product even after a week) and can be attributed to
indazole ligands coordinated to diamagnetic ruthenium centers as they are significantly




Figure 3. H NMR-spectra of Na trans-[RuCl(ind)2] in ethanol-d6 after 0, 2, 4 and 6 hours at 37C
between a chemical shift of a) 2.1 and 4.0 ppm (left) and b)-7 and -20 ppm (right).
The transformation into one main solvolysis product is also obvious in the UV/vis spectra
taken at a temperature of 37C during the first six hours (see figure 5a). The transformation of
the original complex is characterized by isosbestic points at 261, 304, 339, 355 and 404 nm.
No band above 415 nm can be detected. No further changes, especially no precipitation can
be observed within two days of observation period.
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In an ethanol/water mixture (1/1) the changes in the UV/vis-spectra are different. In contrast
to the spectra in pure ethanol, a band rises at 578 nm (see figure 5b). The transformation of
the complex is characterized by isosbestic points at 276, 310, 361 and 445 nm. Whereas
hydrolysis of Na trans-[RuCI4(ind)2] in pure water leads to precipitation (see below), this can
not be observed in ethanol/water mixtures.
Four signals at a chemical shift of-17.9, 1.27, 2.09, 2.41 and 2.80 ppm can be detected in
the 1H NMR spectrum for the complex trans-[RuCI4(ind)2], just after dissolving the sodium salt
in ethanol /water (1/1). The signals are slightly shifted compared to pure DO (see below).
New signals arise at 1.68, 1.87 and 3.18 ppm but their intensity never exceeds one third of
the signals of the ,,fresh" solution. After three hours a precipitation starts that is finished after
eight hours.
b
Figure 4. UV/vis-spectra of Na trans-[RuCI4(ind)2] in a) ethanol during 6 hours at 37C (225-550 nm) and
b) ethanol/water (1/1) during 12 hours at 37C (225-700 nm).
Hind trans-[RuCI4(ind)] reacts quite similar to Na trans-[RuCI4(ind)]. We found no evidence for
the interference of the counterion or the formation of the neutral trisindazole complex mer-
[RuCI3(ind)3] under the conditions mentioned, mer-[RuCl3(ind)] can only be obtained on
refluxing a suspension of Hind trans-[RuCI4(ind)] in solvents like tetrahydrofuran or ethyl
acetate (to be published).
3.2. Hydrolysis of Na trans-[RuCl(ind)]
The hydrolytic reactions of the imidazole complex Him trans-[RuCI4(im)2] have already been
investigated by means of 1H NMR spectroscopy, although the information derived from NMR
techniques is limited due to the paramagnetic Ru(lll)center. In unbuffered solutions of Him
trans-[RuCI4(im)] new signals that have been assigned to a monoaqua complex and the two
possible diaqua complexes arised. Interpretation of the more complicated spectra obtained
in phosphate-buffered solutions was not possible [16].
In contrast to the imidazole complex, no changes in chemical shifts can be observed if a
solution of the indazole complex Na trans-[RuCI4(ind)] in DO is investigated with H NMR
spectroscopy (The solubility of the indazolium salt Hind trans-[RuCI4(ind)] is not good enough
for H NMR studies). However, precipitation occurs soon and the intensity of the unchanged,
paramagnetically shifted peaks at-18.3, 1.30, 2.18, 2.47 and 3.04 ppm decreases. Thus, at
least one hydrolysis product is formed which immediately precipitates and therefore can’t be
detected in solution with NMR. A H NMR of the precipitate dissolved in dmso-d6 shows
signals of the same intensity at a chemical shift of 3.64, 3.71, 4.19 and 4.49 ppm presumably
belonging to one single paramagnetic species. Additional sharp peaks of much lower
intensity (under 2%)occur in the aromatic region at 7.17, 7.40, 7.80 and 8.75 ppm. These
signals should derive from coordinated indazole protons of diamagnetic species. In the
upfield region two very broad signals at-4 and -10 ppm can be detected.
One possible hydrolysis product would be the monoaqua complex [RuCI3(H20)(ind)] or the
corresponding hydroxo complex, respectively. The neutral monoaqua complex should be
less soluble in water. If it is withdrawn from solution by precipitation, no further hydrolysis
reaction could take place and be detected in solution. Nevertheless, the formation of soluble
hydrolysis products without NMR-detectable protons, like those of the indazole ligands, can
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not be ruled out (see UV/vis experiments). An elemental analysis of the precipitate of Na
trans-[RuCI4(ind)2] in water is within a tolerable margin for C, H and N but the CI content
differs by 1.1% from the value calculated for the monoaquacomplex. The crystal structure of
the monoaqua complex of the N-1 methylated indazole complex [RuCI3(H20)(1-Me-ind)]
could already be solved [17]. The crystals could be obtained by evaporating a solution of
H(1-Me-ind) trans-[RuCl3(HO)(1-Me-ind)] in acetone water (1/1).
In contrast to the NMR experiments, changes of a solution of Na trans-[RuCI4(ind)] in water
can be seen in the UV/vis-spectra. Figure 5a shows the changes in the UV/vis spectra during
the first eight hours at 37C. Together with the formation of a band at 578 nm a diffused
background absorption caused by precipitation can be observed, resulting in an increased
baseline. Nevertheless, one has to be aware of the more than 100 times smaller
concentration of Na trans-[RuCI4(ind)2] in the solution of the UV/vis compared to the NMR
experiment. Therefore, different hydrolysis pathways can not be excluded.
Hydrolysis, of course, proceeds slower at room temperature or at 4C, where no changes in
UV/vis spectra can be observed even after days. This is important to notice with regard to a
clinical application and storage of solutions of Na trans-[RuCl4(ind)].
Figure 5. a) UV/vis spectra (225-670 nm) of Na trans-[RuCl,(ind)2] in aqueous solution at 37C during the
first 8 hours’ b) UV/vis spectra (225-550 nm) of Na trans-[RuCI4(ind)2] at 37C over 10 min in a buffer
consisting of 0.004 M NaH2PO4, 0.025 M NaHCO3 and 0.1 M NaCI.
Reaction of Na trans-[RuCI4(ind)] in a solution buffered to pH 7.4 with phosphate buffer is
faster than in pure water (DO). 1H NMR spectra give only little information about the
hydrolytic process as precipitation occurs even faster and only a decrease in intensity but no
change in the chemical shifts of the protons assigned to the complex trans-[RuCI4(ind)] can
be detected. The dark precipitate is poorly soluble in dmso. The ’H NMR in dmso-d6 reveals
a number of signals similar to those of the precipitate obtained in pure water and additional
four small signals between 11.5 and 13 ppm. The signals between 7.1 and 8.8 ppm are more
intense as in the case of the pure water solution (about 25%). The UV/vis spectra are quite
similar to those for pure water, revealing the formation of a band at 578 nm and precipitation.
Hydrolysis of the complex trans-[RuCl,(ind)2] is much slower at lower pH levels, whereas it is
significantly faster at higher pH levels. If the pH of a solution of trans-[RuCI4(ind)] at 37C is
adjusted to 3.5 with orthophosphoric acid, the transformation of the complex is indicated by
intensity changes of the bands at 287, 357 and 417 nm and isosbestic points at 272, 308 and
344 nm in the UV/vis spectra during the first five hours after dissolving the complex. After this
initial transformation further changes in the UV/vis spectra can be detected, characterized by
isosbestic points at 357, 464 and 647 nm and the formation of a new band at 578 nm. The
band at 578 nm reaches its maximum after 60 h at 37C, followed by a decrease in
absorbance in the whole wave length region because of precipitation. This band at 578 nm
is a good indicator to demonstrate the pH-dependence of the hydrolysis. Figure 6a shows a
plot of the time after first appearence of the band at 578 nm in the visible spectra against the
pH of buffered solutions of Na trans-[RuCI4(ind)].
Na trans-[RuCl(ind)] and Hind trans-[RuCl,(ind)] show a total different behaviour if NaHCO is
present in aqueous solution or if a physiological buffer, consisting of 0.004 M NaH2PO4, 0.025
M NaHCO and 0.1 M NaCI, is used, respectively. A solution of Na trans-[RuCl,(ind)2] in this
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HCO3 containing buffer (pH 7.4) changes color to green and further on to green-blue within
minutes and precipitation occurs after 15 minutes. Figure 6b shows repetitive scan spectra
during the first ten minutes, revealing the formation of one new species, characterized by
isosbestic points at 298 and 350 nm. After standing for one day the solution is totally
colorless. The 1H NMR of the precipitate dissolved in dmso-d6 reveals sharp signals at 8.06 [s,
H at C-3], 7.74[m, H at C-4], 7,52 [m, H at C-7], 7.32 [m, H at C-5], 7.08 [m, H at C-6] and
13.06 ppm that fit perfectly the chemical shifts of the indazolium ion in dmso-d6 solution.
These signals are overlapped by a very broad signal centered at 7.2 ppm (see figure 6b). No
other signals could be detected. Thus, the indazole ligands seem to be released, at least in
part. Whether the precipitate consists of a monomeric, dimeric or polymeric species or a
mixture of species can not be ruled out based on these investigations.
Important to notice is the fact that HCO3 has no comparable influence on the hydrolysis of
Him trans-[RuCI4(im)2]. Whereas hydrolysis of the imidazole complex is faster in water or
phosphate buffer, the situation changes dramatically in buffer systems containing hydrogen
carbonate. In these buffer systems also binding towards serum proteins was found to be faster.
If a citrate phosphate buffer is used a similar behaviour can be observed, probably due to
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Figure 6. a) Time of first appearance of the band at 578 nm in visible spectra of Na trans-[RuCI4(ind)2] at
different pH values of buffered solutions at 37C b) 1H NMR in dmso-d6 of the precipitate obtained from
a solution of Na trans-[RuCI4(ind)2] in a buffer consisting of 0.004 M NaH2PO4, 0.025 M NaHCO3 and 0.1
M NaCI.
3.3. Conclusions
Whereas solvolysis of the complex trans-[RuCl(ind)2] in organic solvents or aqueous mixtures
of solvents like ethanol, acetonitrile and dmso seems to lead for the most part to one main
product, hydrolysis in water or buffered aqueous solution is more intricate. Solvolysis in
ethanol and acetonitrile water presumably leads to neutral, monosubstituted ruthenium
solvento complexes.
The solvolytic decomposition of the complex trans-[RuCl(ind)2] is characterized by
substitution of one or more of the chloro ligands. An initial formation of the neutral
monoaquacomplex [RuCl(HO)(ind)2] seems to be necessary for further transformation in all
solvent systems as no reaction occurs in absolute dmso and acetonitrile within days. The
formation of an aquacomplex is also likely because pH decreases in an unbuffered solution
of Na trans-[RuCl,(ind)] in water (data not shown). This lowering of pH should be caused by a
deprotonation of the formed aquacomplex(es), leading to the corresponding
hydroxocomplex(es). The formed hydroxo complexes could then further react to di- or
polynuclear hydroxo-or oxo-bridged species, respectively. These reactions should be
accelerated at higher pH levels. As we found a strong pH dependence of the hydrolysis, the
formation of I-OXO complexes might be one of the possible reaction pathways. Additionally, a
release of the indazole ligands can not be excluded although the Ru(lll)-nitrogen bonds in
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these kind of ruthenium complexes with N-heterocyclic ligands are assumed to be rather
inert.
A totally different hydrolysis pathway is followed in the case of the buffer containing NaHCO3.
The hydrolysis is much faster and release of indazole could be demonstrated.
This striking influence of HCO3 on the hydrolytic decomposition of trans-[RuCI4(ind)2] is
important to notice, especially in comparison to the imidazole complex trans-[RuCl4(im)2].
Whereas the imidazole complex hydrolyzes faster than the indazole complex in water or
phosphate buffer, the situation changes dramatically in physiological buffer containing
hydrogen carbonate. A total change in the coordination sphere of the ruthenium complex
seems to take place. The formed species react very fast with serum proteins under these
conditions [22] (No precipitation occurs if serum proteins are present). Whereas the indazole
complex is more stable in water than the imidazole complex, and enough stable with regard
to a clinical application, reactions in the blood can proceed much faster compared to the
imidazole complex. This might be one of the reasons for the significantly lower toxicity of the
indazole complex.
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